| Mrs Juli A Park Jankowski, RPH | |
|
1788 Old Hudson Rd, Saint Paul, MN 55119-4307 | |
| (651) 731-9633 | |
| (651) 731-9678 |
| Full Name | Mrs Juli A Park Jankowski |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1788 Old Hudson Rd, Saint Paul, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003183633 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 4546 (South Dakota) | Secondary |
| 183500000X | Pharmacist | 114936 (Minnesota) | Secondary |
| 183500000X | Pharmacist | 1149368 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Juli A Park Jankowski, RPH 1788 Old Hudson Rd, Saint Paul, MN 55119-4307 Ph: (651) 731-9633 | Mrs Juli A Park Jankowski, RPH 1788 Old Hudson Rd, Saint Paul, MN 55119-4307 Ph: (651) 731-9633 |
News Archive
Cells give up their secrets slowly. Just when you think that all major cellular systems are understood, along comes a surprise. The latest is about autophagy, a major pathway for degrading and recycling within cells.
The study, reported in Nature (Oct. 13, 2005), focuses on the Hedgehog family of signaling molecules, which play a central role in directing development of the early embryo's growth and spatial plan, as well as its later organ and limb development. Defects in Hedgehog signaling are a significant cause of some birth defects and cancers.
Medicare patients nationwide have low rates of preventive care visits – with the lowest rates found in older adults of minority race/ethnicity, reports a study in the September issue of Medical Care. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Avanir Pharmaceuticals, Inc. today announced that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a large Phase II clinical trial of AVP-923, an investigational drug for the treatment of central neuropathic pain in patients with multiple sclerosis (MS). The FDA has acknowledged receipt of the submission and the company expects that the IND filing will be subject to standard 30-day review.
New research that provides a better understanding of pancreatic cancer may help identify individuals at increased risk. The findings are published early online in Cancer, a peer-reviewed journal of the American Cancer Society.
› Verified 7 days ago
Beth J Alexander, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1302 Palace Ave, Saint Paul, MN 55105 Phone: 651-699-0290 Fax: 612-330-1757 | |
Avni A Novotny, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2199 Highway 36 E, Saint Paul, MN 55109 Phone: 651-779-6341 Fax: 651-234-4734 | |
Dr. Eddie Kit Huie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 734 Grand Ave, Saint Paul, MN 55105 Phone: 651-227-5422 | |
Fan Zhang, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 345 Smith Ave N, Saint Paul, MN 55102 Phone: 651-220-6820 | |
Dr. Justin Lee Anderson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 153 Cesar Chavez St, Saint Paul, MN 55107 Phone: 651-602-7589 | |
Jeff Ray Digre, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1440 University Ave W, Saint Paul, MN 55104 Phone: 651-646-8858 Fax: 651-646-9699 |